Journey Medical Corporation (NASDAQ: DERM) Stock Information | RedChip

Journey Medical Corporation (NASDAQ: DERM) Listen to this Section


$4.46
-0.1000 ( -2.19% ) 59.8K

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

Market Data


Open


$4.46

Previous close


$4.56

Volume


59.8K

Market cap


$91.82M

Day range


$4.39 - $4.96

52 week range


$1.78 - $8.11

Insider Ownership Transactions

Total Amount Purchased: 247,604.00 | $ 1,104,313.84

Date Type Amount Purchased Purchaser
2024-03-25 Buy 30000.00 Smith Justin Adam
2024-03-25 Buy 20000.00 ROSENWALD LINDSAY A MD
2024-02-23 Sale -2450.00 Benesch Joseph
2023-12-08 Sale -2245.00 Paley Jeffrey
2023-11-29 Sale -1745.00 Paley Jeffrey
2023-10-17 Buy 33000.00 Smith Justin Adam
2023-10-10 Buy 15000.00 Paley Jeffrey
2023-09-25 Buy 30000.00 Paley Jeffrey
2023-09-08 Buy 26044.00 Maraoui Claude
2023-09-08 Buy 100000.00 ROSENWALD LINDSAY A MD

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jul 10, 2024
8-k 8K-related 14 Jun 25, 2024
4 Insider transactions 1 May 31, 2024
3 Insider transactions 1 May 31, 2024
10-q Quarterly Reports 85 May 14, 2024
8-k 8K-related 15 May 13, 2024
8-k 8K-related 15 May 01, 2024
def Proxies and info statements 4 Apr 29, 2024
10-k Annual reports 106 Mar 29, 2024
4 Insider transactions 1 Mar 27, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.